Data / Form D filings / Sea Pharmaceuticals, LLC
Sea Pharmaceuticals, LLC: Form D filings
Sea Pharmaceuticals, LLC, a pharmaceuticals company in Cambridge, MA, filed 12 Form D notices with the SEC between 2016 and 2026. The latest, on May 20, 2026, reports $71,100 sold of a $1.7 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14 GRAY STREET, Cambridge, MA, 02138
- Phone
- (617) 838-5082
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Iowa
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1667677
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | Amendment | $1,742,321 | $71,100 | $1,671,221 | 7 | Jul 17, 2025 | sec.gov |
| May 14, 2025 | New notice | $1,742,321 | $0 | $1,742,321 | 0 | Yet to occur | sec.gov |
| Feb 11, 2025 | Amendment | $2,175,701 | $417,380 | $1,758,321 | 16 | Dec 29, 2023 | sec.gov |
| Oct 11, 2023 | New notice | $2,175,701 | $0 | $2,175,701 | 0 | Yet to occur | sec.gov |
| Jan 26, 2023 | Amendment | $2,000,000 | $1,490,435 | $509,565 | 27 | Mar 13, 2019 | sec.gov |
| Jan 14, 2022 | Amendment | $2,000,000 | $1,087,693 | $912,307 | 26 | Mar 13, 2019 | sec.gov |
| Feb 1, 2021 | Amendment | $2,000,000 | $627,887 | $1,372,113 | 19 | Mar 13, 2019 | sec.gov |
| Jan 31, 2020 | Amendment | $2,000,000 | $263,769 | $1,736,231 | 13 | Mar 13, 2019 | sec.gov |
| Feb 27, 2019 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Nov 17, 2017 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Nov 16, 2016 | Amendment | $3,500,000 | $887,000 | $2,613,000 | 38 | Feb 19, 2016 | sec.gov |
| Feb 29, 2016 | New notice | $1,500,000 | $200,000 | $1,300,000 | 4 | Feb 19, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James P. Pearson | Executive Officer, Director | President, Chief Executive Officer, Chief Science Officer |
| Walter Kendall Brown | Director | |
| Eric R Olson | Director | |
| Michael J. Higgins | Director | |
| Nabil Elkouh | Director | |
| Shaker Sadasivam | Director | |
| Mark G. Currie | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of May 18, 2026 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sea Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.